Surgical Science has today announced that Invesco’s fund Invesco Global Opportunities has become shareholder in Surgical Science through the acquisition of 800,000 shares. The shares were bought from two board members, Roland Bengtsson and Jan Bengtsson, who through their respective companies sold shares to Invesco.
“We have seen increased interest from North American investors in Surgical Science and are pleased to have Invesco as one of the company’s 15 largest owners. It is a long-term owner with a very good reputation and significant financial muscle”, says Gisli Hennermark, CEO of Surgical Science.
Frank Jennings is Senior Portfolio Manager for Invesco Global Opportunities, which invests in small and midcap growth companies globally. Frank was a portfolio manager for over 20 years at OppenheimerFunds before they became part of Invesco in 2019. Invesco has total assets of approximately USD 1,500 billion under management.
Gothenburg, Sweden, July 5, 2022
Surgical Science Sweden AB (publ)